Find clinical trials for Adenocarcinoma in Houston, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Adenocarcinoma trials near Houston, TX, USA:
with neoadjuvant chemotherapy for the treatment of treatment-naïve subjects with borderline resectable and locally advanced pancreatic ductal adenocarcinoma...
Phase 1
Houston, Texas, United States and 5 other locations
of multi-dose dendritic cell (DC) therapy for pancreatic ductal adenocarcinoma (PDAC) including adenosquamous carcinoma administered after s...
Phase 1
Houston, Texas, United States and 2 other locations
The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.
Phase 3
Webster, Texas, United States and 22 other locations
participants to treat locally advanced unresectable or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma (mGEA).T...
Phase 2
Houston, Texas, United States and 48 other locations
This study has stopped recruitment.Adults with advanced pancreatic cancer participate in this study. The study tests a type of immunotherapy. It is a...
Phase 1
Houston, Texas, United States and 20 other locations
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
Houston, Texas, United States and 118 other locations
cancer Trial Phase: Phase II Clinical Indication: Pancreatic ductal adenocarcinoma; Adenocarcinoma; AJCC I, II, or III; 1st Line ne...
Phase 2
Houston, Texas, United States and 2 other locations
unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma trial is to compare OS between cadonilimab combined with...
Phase 3
Houston, Texas, United States and 24 other locations
This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer,...
Phase 1, Phase 2
Houston, Texas, United States and 13 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.
Phase 3
Houston, Texas, United States and 59 other locations
Clinical trials
Research sites
Resources
Legal